Adaptimmune Therapeutics PLC (ADAP)
0.8246
+0.02
(+3.10%)
USD |
NASDAQ |
Nov 04, 16:00
0.8246
0.00 (0.00%)
After-Hours: 20:00
Adaptimmune Therapeutics Price to Book Value: 2.190 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 2.125 |
| October 31, 2024 | 1.928 |
| October 30, 2024 | 1.851 |
| October 29, 2024 | 1.872 |
| October 28, 2024 | 1.958 |
| October 25, 2024 | 1.959 |
| October 24, 2024 | 1.992 |
| October 23, 2024 | 2.085 |
| October 22, 2024 | 2.152 |
| October 21, 2024 | 2.188 |
| October 18, 2024 | 2.239 |
| October 17, 2024 | 2.235 |
| October 16, 2024 | 2.314 |
| October 15, 2024 | 2.338 |
| October 14, 2024 | 2.335 |
| October 11, 2024 | 2.315 |
| October 10, 2024 | 2.335 |
| October 09, 2024 | 2.363 |
| October 08, 2024 | 2.414 |
| October 07, 2024 | 2.417 |
| October 04, 2024 | 2.526 |
| October 03, 2024 | 2.378 |
| October 02, 2024 | 2.324 |
| October 01, 2024 | 2.448 |
| September 30, 2024 | 2.525 |
| Date | Value |
|---|---|
| September 27, 2024 | 2.596 |
| September 26, 2024 | 2.489 |
| September 25, 2024 | 2.442 |
| September 24, 2024 | 2.579 |
| September 23, 2024 | 2.492 |
| September 20, 2024 | 2.646 |
| September 19, 2024 | 2.683 |
| September 18, 2024 | 2.763 |
| September 17, 2024 | 2.789 |
| September 16, 2024 | 2.789 |
| September 13, 2024 | 2.949 |
| September 12, 2024 | 2.922 |
| September 11, 2024 | 2.869 |
| September 10, 2024 | 2.869 |
| September 09, 2024 | 2.949 |
| September 06, 2024 | 2.896 |
| September 05, 2024 | 2.949 |
| September 04, 2024 | 3.082 |
| September 03, 2024 | 3.214 |
| August 30, 2024 | 3.374 |
| August 29, 2024 | 3.374 |
| August 28, 2024 | 3.241 |
| August 27, 2024 | 3.294 |
| August 26, 2024 | 3.533 |
| August 23, 2024 | 3.214 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5163
Minimum
Nov 15 2019
15.41
Maximum
Apr 01 2024
3.193
Average
2.499
Median
Price to Book Value Benchmarks
| Biodexa Pharmaceuticals PLC | 0.2989 |
| Verona Pharma PLC | 18.43 |
| NuCana PLC | 0.7432 |
| Autolus Therapeutics PLC | 1.686 |
| Bicycle Therapeutics PLC | 1.952 |
Price to Book Value Related Metrics
| PS Ratio | 1.392 |
| Price | 0.8246 |
| Earnings Yield | -36.38% |
| Market Cap | 210.89M |